Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Data
Biotech
Response’s ex-Sanofi asset hits goal in post-GLP-1 patients
Response shared phase 2 data, linking its asset to reductions in blood-fat levels and weight gain in post-GLP-1 patients.
Nick Paul Taylor
Aug 13, 2025 9:14am
Trinity Biotech says its 15-day CGM works without fingersticks
Aug 12, 2025 12:30pm
HMNC recalibrates precision depression push after phase 2b miss
Aug 5, 2025 10:38am
Praxis' drug reduces seizures but sees 23% discontinuation rate
Aug 4, 2025 10:22am
4DMT climbs as gene therapy patients keep jettisoning jabs
Aug 1, 2025 5:35am
Cardiff posts updated colorectal cancer data, sinking stock
Jul 30, 2025 7:25am
